title: Elevated FSH concentrations in imminent ovarian failure are associated with higher FSH and LH pulse amplitude and response to GnRH.
abstract: Imminent ovarian failure (IOF) in women is characterized by regular menstrual cycles and elevated early follicular phase FSH. This study explored underlying neuroendocrine causes of elevated FSH concentrations on day 3 of the menstrual cycle. The characteristics of episodic secretion of FSH and LH, the pituitary response to gonadotrophin-releasing hormone (GnRH), plasma oestradiol, and dimeric inhibin A and inhibin B on day 3 were compared in 13 women with elevated FSH concentrations (>10 IU/l) and 16 controls. FSH amplitudes were higher in the IOF group than in the controls (P < 0. 0001). The FSH pulse frequency did not differ between groups. The FSH response to GnRH was higher in the IOF patients than in the controls (P < 0.0001). Mean LH, LH amplitude and LH response to GnRH were higher in the IOF group, but LH pulse frequency did not differ between the groups. Concentrations of inhibin A and inhibin B were lower in the IOF group, while oestradiol showed no differences. We concluded that in women with IOF, the pituitary is more sensitive to GnRH. This leads to higher FSH and LH pulse amplitudes which underlie the elevated FSH concentrations in the early follicular phase.
authors.affiliation: Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology,Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands. c.dekoning@azvu.nl
authors.forename: C H
authors.initials: CH
authors.lastname: de Koning
authors.forename: C
authors.initials: C
authors.lastname: Popp-Snijders
authors.forename: J
authors.initials: J
authors.lastname: Schoemaker
authors.forename: C B
authors.initials: CB
authors.lastname: Lambalk
mesh_terms: D000328:Adult; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood* / Q000378:metabolism*; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006801:Humans; D007265:Inhibins / Q000097:blood; D007986:Luteinizing Hormone / Q000378:metabolism*; D009994:Osmolar Concentration; D016649:Primary Ovarian Insufficiency / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism*; D020033:Protein Isoforms / Q000097:blood; D011673:Pulsatile Flow
chemical_list: D020033:Protein Isoforms; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D007265:Inhibins; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone